Fluorogenic β-Lactamase Substrates for Rapid Tuberculosis Diagnosis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic methods for tuberculosis, such as acid-fast smear and culture-based techniques, are slow and lack specificity for Mycobacterium tuberculosis, leading to delayed detection and potential disease spread, as they are not sensitive or rapid enough for early diagnosis.
Innovation Solution
Development of novel β-lactamase substrates, specifically designed to target BlaC enzyme in M. tuberculosis, which are more sensitive and specific, allowing for rapid detection of tuberculosis through fluorescence-based assays.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If acid-fast smear or culture-based techniques are used for tuberculosis diagnosis, then detection can be performed, but the detection speed is slow and time to diagnosis is extended
Solution Approach 1:
The patent changes the detection parameter from slow-growing bacterial culture to rapid enzymatic reaction. By detecting β-lactamase enzyme activity instead of waiting for bacterial growth, the diagnosis time is dramatically reduced while maintaining detection sensitivity through specific fluorogenic substrate reactions.
Solution Approach 2:
The patent replaces the mechanical/biological process of bacterial culture growth with a chemical/enzymatic detection system. Fluorogenic substrates undergo enzymatic hydrolysis by β-lactamase, producing fluorescent signals that can be detected rapidly without requiring bacterial cultivation.
2Measurement precision
If conventional diagnostic methods are used, then tuberculosis detection is possible, but specificity for M. tuberculosis is insufficient leading to false positives
Solution Approach 1:
The patent applies local quality by designing fluorogenic substrates with specific molecular structures that are selectively recognized and hydrolyzed by BlaC enzyme from M. tuberculosis. The substrates contain specific functional groups and spatial arrangements that match the active site of BlaC, ensuring high specificity while maintaining diagnostic reliability.
Solution Approach 2:
The patent introduces fluorogenic substrates as intermediary molecules that mediate between the target enzyme (BlaC) and the detection system. These substrates specifically interact with BlaC through enzymatic hydrolysis, converting the biological recognition event into a measurable fluorescent signal with high specificity.
3Measurement precision
If existing fluorogenic probes are used for β-lactamase detection, then fluorescence signal can be generated, but the probes are large and display slow hydrolytic kinetics
Solution Approach 1:
The patent segments the probe structure into optimized components with specific molecular weights and functional groups. The fluorogenic substrates are designed with appropriate size and structure to facilitate rapid enzymatic hydrolysis while maintaining fluorescent signal generation, achieving both sensitivity and reaction speed.
Solution Approach 2:
The patent changes the physical-chemical parameters of the fluorogenic substrates, including molecular size, hydrophobicity, and structural configuration. These parameter optimizations enable faster hydrolytic kinetics by BlaC while preserving the ability to generate detectable fluorescent signals.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The new substrates enable rapid and specific detection of M. tuberculosis, reducing the time to diagnosis and improving the accuracy of tuberculosis detection, potentially decreasing disease transmission and mortality rates.
Implementation Method 1
The mechanism of cephalosporin hydrolysis by β-lactamases yields hydrolyzed β-lactam
Implementation Method 2
a number of fluorogenic and bioluminogenic probes have been developed for detection of β-lactamase activity
Data Source
AI summary
β-Lactamase substrates and methods for using the substrates to detect β-lactamase diagnose tuberculosis.